Related references
Note: Only part of the references are listed.Intrapulmonary Bronchopulmonary Anastomoses and Plexiform Lesions in Idiopathic Pulmonary Arterial Hypertension
Csaba Galambos et al.
AMERICAN JOURNAL OF RESPIRATORY AND CRITICAL CARE MEDICINE (2016)
Marked Strain-Specific Differences in the SU5416 Rat Model of Severe Pulmonary Arterial Hypertension
Baohua Jiang et al.
AMERICAN JOURNAL OF RESPIRATORY CELL AND MOLECULAR BIOLOGY (2016)
Regulatory T Cell Dysfunction in Idiopathic, Heritable and Connective Tissue-Associated Pulmonary Arterial Hypertension
Alice Huertas et al.
CHEST (2016)
Vascular stiffness mechanoactivates YAP/TAZ-dependent glutaminolysis to drive pulmonary hypertension
Thomas Bertero et al.
JOURNAL OF CLINICAL INVESTIGATION (2016)
Endothelial-to-Mesenchymal Transition in Pulmonary Hypertension
Benoit Ranchoux et al.
CIRCULATION (2015)
Pulmonary Arterial Hypertension: A Current Perspective on Established and Emerging Molecular Genetic Defects
Rajiv D. Machado et al.
HUMAN MUTATION (2015)
The support of human genetic evidence for approved drug indications
Matthew R. Nelson et al.
NATURE GENETICS (2015)
Survival in systemic sclerosis-pulmonary arterial hypertension by serum autoantibody status in the Pulmonary Hypertension Assessment and Recognition of Outcomes in Scleroderma (PHAROS) Registry
Monique Hinchcliff et al.
SEMINARS IN ARTHRITIS AND RHEUMATISM (2015)
Vascular Receptor Autoantibodies in Pulmonary Arterial Hypertension Associated with Systemic Sclerosis
Mike O. Becker et al.
AMERICAN JOURNAL OF RESPIRATORY AND CRITICAL CARE MEDICINE (2014)
Proteomic Analysis Implicates Translationally Controlled Tumor Protein as a Novel Mediator of Occlusive Vascular Remodeling in Pulmonary Arterial Hypertension
Jessie R. Lavoie et al.
CIRCULATION (2014)
Inflammation and Immunity in the Pathogenesis of Pulmonary Arterial Hypertension
Marlene Rabinovitch et al.
CIRCULATION RESEARCH (2014)
The lysosomal inhibitor, chloroquine, increases cell surface BMPR-II levels and restores BMP9 signalling in endothelial cells harbouring BMPR-II mutations
Benjamin J. Dunmore et al.
HUMAN MOLECULAR GENETICS (2013)
Elderly patients diagnosed with idiopathic pulmonary arterial hypertension: Results from the COMPERA registry
Marius M. Hoeper et al.
INTERNATIONAL JOURNAL OF CARDIOLOGY (2013)
FK506 activates BMPR2 rescues endothelial dysfunction, and reverses pulmonary hypertension
Edda Spiekerkoetter et al.
JOURNAL OF CLINICAL INVESTIGATION (2013)
Targeted gene delivery of BMPR2 attenuates pulmonary hypertension
A. M. Reynolds et al.
EUROPEAN RESPIRATORY JOURNAL (2012)
The extracellular matrix: A dynamic niche in cancer progression
Pengfei Lu et al.
JOURNAL OF CELL BIOLOGY (2012)
The Changing Picture of Patients With Pulmonary Arterial Hypertension in the United States How REVEAL Differs From Historic and Non-US Contemporary Registries
Adaani E. Frost et al.
CHEST (2011)
Fractal branching quantifies vascular changes and predicts survival in pulmonary hypertension: a proof of principle study
Shahin Moledina et al.
HEART (2011)
Sex differences in autoimmune diseases
Rhonda Voskuhl
Biology of Sex Differences (2011)
Formation of Plexiform Lesions in Experimental Severe Pulmonary Arterial Hypertension
Kohtaro Abe et al.
CIRCULATION (2010)
Epigenetic Attenuation of Mitochondrial Superoxide Dismutase 2 in Pulmonary Arterial Hypertension A Basis for Excessive Cell Proliferation and a New Therapeutic Target
Stephen L. Archer et al.
CIRCULATION (2010)
Elevated Levels of Inflammatory Cytokines Predict Survival in Idiopathic and Familial Pulmonary Arterial Hypertension
Elaine Soon et al.
CIRCULATION (2010)
Survival in Patients With Idiopathic, Familial, and Anorexigen-Associated Pulmonary Arterial Hypertension in the Modern Management Era
Marc Humbert et al.
CIRCULATION (2010)
ACCF/AHA 2009 Expert Consensus Document on Pulmonary Hypertension A Report of the American College of Cardiology Foundation Task Force on Expert Consensus Documents and the American Heart Association
Vallerie V. McLaughlin et al.
CIRCULATION (2009)
Genetic ablation of the Bmpr2 gene in pulmonary endothelium is sufficient to predispose to pulmonary arterial hypertension
Kwon-Ho Hong et al.
CIRCULATION (2008)
Emerging concepts and translational priorities in pulmonary arterial hypertension
Evangelos D. Michelakis et al.
CIRCULATION (2008)
Failure of bone morphogenetic protein receptor trafficking in pulmonary arterial hypertension: potential for rescue
Anastasia Sobolewski et al.
HUMAN MOLECULAR GENETICS (2008)
Rho kinase-mediated vasoconstriction is important in severe occlusive pulmonary arterial hypertension in rats
Masahiko Oka et al.
CIRCULATION RESEARCH (2007)
Pulmonary arterial hypertension in France - Results from a national registry
M Humbert et al.
AMERICAN JOURNAL OF RESPIRATORY AND CRITICAL CARE MEDICINE (2006)
Serotonin increases susceptibility to pulmonary hypertension in BMPR2-deficient mice
L Long et al.
CIRCULATION RESEARCH (2006)
Bone morphogenetic protein receptor-2 signaling promotes pulmonary arterial endothelial cell survival - Implications for loss-of-function mutations in the pathogenesis of pulmonary hypertension
K Teichert-Kuliszewska et al.
CIRCULATION RESEARCH (2006)
Autoimmunity and pulmonary hypertension: a perspective
MR Nicolls et al.
EUROPEAN RESPIRATORY JOURNAL (2005)
Rescue of monocrotaline-induced pulmonary arterial hypertension using bone marrow-derived endothelial-like progenitor cells - Efficacy of combined cell and eNOS gene therapy in established disease
YDD Zhao et al.
CIRCULATION RESEARCH (2005)
Pulmonary hypertension in transgenic mice expressing a dominant-negative BMPRII gene in smooth muscle
J West et al.
CIRCULATION RESEARCH (2004)
Primary pulmonary hypertension, Castleman's disease and human herpesvirus-8
TM Bull et al.
EUROPEAN RESPIRATORY JOURNAL (2003)
Primary pulmonary hypertension is associated with reduced pulmonary vascular expression of type II bone morphogenetic protein receptor
C Atkinson et al.
CIRCULATION (2002)
Share Paper
